SAN FRANCISCO, Feb. 23, 2021 /PRNewswire/ -- Invitae Corporation
(NYSE: NVTA), a leading medical genetics company, today announced
expanded capabilities that enable clinicians to use its advanced
clinical chatbot Gia to guide their patients in an intuitive,
enjoyable and telemedicine-friendly conversation through receiving
and understanding genetic test results and possible next steps,
including scheduling a call with a genetics counselor.
![Invitae's (NVTA) mission is to bring comprehensive genetic information into mainstream medical practice to improve the quality of healthcare for billions of people. www.invitae.com (PRNewsFoto/Invitae Corporation) Invitae's (NVTA) mission is to bring comprehensive genetic information into mainstream medical practice to improve the quality of healthcare for billions of people. www.invitae.com (PRNewsFoto/Invitae Corporation)](https://mma.prnewswire.com/media/268592/invitae_corporation_logo.jpg)
"While the pandemic brought new urgency to the need for
telemedicine-friendly patient tools, we've known for a long time
that Gia can make the genetic testing process easier and more
accessible for both patients and clinicians," said Moran Snir, co-developer of Gia and head of
experience platform at Invitae. "By adding support for returning
results to Gia's capabilities, we can help reduce delays caused by
wait lists for in-person appointments and hours of travel to
appointments, while freeing up genetic counselors to provide
intensive counseling and support for patients who need it. These
kinds of tools are essential for helping more clinicians
incorporate genetics into routine clinical care for their
patients."
Gia provides an industry-leading patient genetics chatbot
experience. The chatbot is integrated into software that supports
clinical workflow throughout the genetic testing process, from
pretest education to family history gathering and ordering support
and continuing through post-test education. Coupled with Invitae's
full suite of software solutions that provide comprehensive
workflow support, a wide variety of clinicians such as
obstetrician/gynecologists, oncologists and genetic counselors can
use Gia to help them integrate routine genetic testing into patient
care. Importantly, chatbot technology also helps clinicians
overcome disparities in access to genetic information by addressing
language and socioeconomic barriers.
Gia, which stands for "genetic information assistant," was
designed in partnership with genetic counselors to help streamline
communication between patients and clinicians. Launched in 2017 and
deployed by major academic health systems, the platform has helped
more than 100,000 patients with pretest education and intake and
post-test counseling. Gia is HIPAA-compliant and has a 92%
satisfaction rate among patients. Gia is available to clinicians in
the United States.
To learn more, visit www.invitae.com/gia.
About Invitae
Invitae Corporation (NYSE: NVTA) is a
leading medical genetics company, whose mission is to bring
comprehensive genetic information into mainstream medicine to
improve healthcare for billions of people. Invitae's goal is to
aggregate the world's genetic tests into a single service with
higher quality, faster turnaround time, and lower prices. For more
information, visit the company's website at invitae.com.
Safe Harbor Statement
This press release contains
forward-looking statements within the meaning of the Private
Securities Litigation Reform Act of 1995, including statements
relating to the benefits and capabilities of Gia. Forward-looking
statements are subject to risks and uncertainties that could cause
actual results to differ materially, and reported results should
not be considered as an indication of future performance. These
risks and uncertainties include, but are not limited to: the
company's history of losses; the company's ability to compete; the
company's failure to manage growth effectively; the company's need
to scale its infrastructure in advance of demand for its tests and
to increase demand for its tests; the company's ability to use
rapidly changing genetic data to interpret test results
accurately and consistently; security breaches, loss of data and
other disruptions; laws and regulations applicable to the company's
business; and the other risks set forth in the company's filings
with the Securities and Exchange Commission, including the risks
set forth in the company's Quarterly Report on Form 10-Q for the
quarter ended September 30, 2020.
These forward-looking statements speak only as of the date hereof,
and Invitae Corporation disclaims any obligation to update these
forward-looking statements.
Contact:
Laura D'Angelo
pr@invitae.com
(628) 213-3283
###
View original content to download
multimedia:http://www.prnewswire.com/news-releases/invitae-expands-capabilities-of-its-advanced-clinical-chatbot-gia-enhancing-telemedicine-support-for-patients-and-clinicians-301233020.html
SOURCE Invitae Corporation